Data gathered: November 28
Alternative Data for MetLife
About MetLife
MetLife Inc provides life insurance, annuities, employee benefits and asset management in the United States, Japan, Latin America, Asia, Europe and the Middle East.
| Price | $88.25 |
| Target Price | Sign up |
| Volume | 3,000,000 |
| Market Cap | $60.8B |
| Year Range | $66.96 - $88.25 |
| Dividend Yield | 2.48% |
| PE Ratio | 17.8 |
| Analyst Rating | 100% buy |
| Industry | Insurance |
In the news
 |
MetLife Pet Insurance: Plans starting at $29November 27 - Dealnews.com |
 |
Intel Faces Institutional Shifts as MetLife Cuts Stake by 2.3%November 27 - Yahoo |
 |
MetLife (NYSE:MET) Rating Increased to Buy at StockNews.comNovember 26 - ETF Daily News |
 |
MetLife's Malaysia Center of Excellence Celebrates 5th AnniversaryNovember 25 - Investing.com |
 |
MetLife Upgraded To Buy As Financials And Insurance Show Further Upside PotentialNovember 25 - SeekingAlpha |
U.S. Pet Insurance Market Analysis Report 2025-2030, with Profiles of Trupanion, Fetch Pet Insurance, Spot Pet Insurance, MetLife, Odie Pet Insurance, Crum & Foster and ManyPetsNovember 25 - GlobeNewswire |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 18.4B | 26.2B | -7.73B | 1.34B | 0 | 1.930 |
| Q2 '24 | 17.8B | 27.8B | -9.99B | 946M | 1.2B | 2.280 |
| Q1 '24 | 16.1B | 25.8B | -9.74B | 867M | 1.04B | 1.830 |
| Q4 '23 | 19B | 29.2B | 19B | 607M | 808M | 1.930 |
| Q3 '23 | 15.9B | 27.3B | -11.4B | 489M | -78M | 1.950 |
Insider Transactions View All
| PAPPAS BILL filed to sell 57,768 shares at $72.3. March 20 '24 |
| TADROS RAMY filed to sell 146,981 shares at $71.9. March 14 '24 |
| Khalaf Michel filed to sell 385,987 shares at $65.9. February 7 '24 |
| DEBEL MARLENE filed to sell 77,638 shares at $63.2. August 11 '23 |
| Johnson Jeh C. filed to buy 2,526 shares at $51.7. December 18 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
AllstateALL |
$208.2 0% | 59 |
 |
ProgressivePGR |
$266.86 0% | 61 |
 |
AflacAFL |
$114.1 0% | 58 |
 |
LemonadeLMND |
$49.16 0% | 41 |
 |
Oscar HealthOSCR |
$16.83 0% | 49 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $1K - $15K |
| Thomas Carper Democrat |
Feb 2, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
Read more about MetLife (MET) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of MetLife?
The Market Cap of MetLife is $60.8B.
What is MetLife's PE Ratio?
As of today, MetLife's PE (Price to Earnings) ratio is 17.8.
What is the current stock price of MetLife?
Currently, the price of one share of MetLife stock is $88.25.
How can I analyze the MET stock price chart for investment decisions?
The MET stock price chart above provides a comprehensive visual representation of MetLife's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling MetLife shares. Our platform offers an up-to-date MET stock price chart, along with technical data analysis and alternative data insights.
Does MET offer dividends to its shareholders?
Yes, MetLife (MET) offers dividends to its shareholders, with a dividend yield of 2.48%. This dividend yield represents MetLife's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering MetLife in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of MetLife?
Some of the similar stocks of MetLife are Allstate, Progressive, Aflac, Lemonade, and Oscar Health.
.